Journal of Clinical Endocrinology & Metabolism, Vol 67, 1294-1298, Copyright © 1988 by Endocrine Society

ARTICLES

Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course

DS Rao, RJ Wilson, M Kleerekoper and AM Parfitt
Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan 48202.

We studied the natural history of primary hyperparathyroidism in patients in whom the disease was discovered fortuitously by multichannel biochemical screening and who were selected for conservative management because they were asymptomatic, had no renal stone disease or radiographic osteitis fibrosa, and had serum calcium values below 3.00 mmol/L, serum creatinine levels below 133 mumol/L, and forearm bone density not more than 2.5 SD below the mean expected for age, sex, and race. One hundred and seventy-four patients meeting these criteria were encountered during a 10-yr period, of whom 80 (mean age, 61 yr) had adequate follow-up; they did not differ significantly in any initial characteristic from the remaining 94 patients. These 80 patients were followed for 1-11 yr (mean, 46 months; median, 38 months), during which there was no change, mean or individual, in any index of PTH secretion or any of its biochemical effects and no decline in forearm bone density apart from that expected from increased age. There were 4 deaths from causes unrelated to hyperparathyroidism, and the overall death rate was not increased. The data suggest that no change occurred in either the number of parathyroid cells or secretory set-point, the 2 principal determinants of basal PTH secretion. This implies a biphasic course, with a short period of disease progression followed by a long period of disease stability. Our data support the decision to withhold surgical intervention in such patients, but to establish this as the correct policy for all asymptomatic patients will require a controlled clinical trial.

This article has been cited by other articles:

				H. Kaji, M. Yamauchi, R. Nomura, and T. Sugimoto Improved Peripheral Cortical Bone Geometry after Surgical Treatment of Primary Hyperparathyroidism in Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3045 - 3050. [Abstract] [Full Text] [PDF]

				H. Lowe, D. J. McMahon, M. R. Rubin, J. P. Bilezikian, and S. J. Silverberg Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3001 - 3005. [Abstract] [Full Text] [PDF]

				M. D. Walker and S. J. Silverberg Parathyroidectomy in Asymptomatic Primary Hyperparathyroidism: Improves "Bones" but not "Psychic Moans" J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1613 - 1615. [Full Text] [PDF]

				E. Hagstrom, E. Lundgren, J. Rastad, and P. Hellman Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol., July 1, 2006; 155(1): 33 - 39. [Abstract] [Full Text] [PDF]

				I. Charopoulos, S. Tournis, G. Trovas, P. Raptou, P. Kaldrymides, G. Skarandavos, K. Katsalira, and G. P. Lyritis Effect of Primary Hyperparathyroidism on Volumetric Bone Mineral Density and Bone Geometry Assessed by Peripheral Quantitative Computed Tomography in Postmenopausal Women J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1748 - 1753. [Abstract] [Full Text] [PDF]

				A. Grey, J. Lucas, A. Horne, G. Gamble, J. S. Davidson, and I. R. Reid Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2122 - 2126. [Abstract] [Full Text] [PDF]

				D. S. Rao, E. R. Phillips, G. W. Divine, and G. B. Talpos Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5415 - 5422. [Abstract] [Full Text] [PDF]

				S. J. Silverberg and J. P. Bilezikian "Incipient" Primary Hyperparathyroidism: A "Forme Fruste" of an Old Disease J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5348 - 5352. [Abstract] [Full Text] [PDF]

				H. A. Sorensen Surgery for primary hyperparathyroidism BMJ, October 12, 2002; 325(7368): 785 - 786. [Full Text] [PDF]

				E. A. Mittendorf and C. R. McHenry Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 275 - 279. [Abstract] [Full Text] [PDF]

				P. Vestergaard, C. L Mollerup, V. G. Frøkjær, P. Christiansen, M. Blichert-Toft, and L. Mosekilde Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism BMJ, September 9, 2000; 321(7261): 598 - 602. [Abstract] [Full Text]

				D. S. Rao, M. Honasoge, G. W. Divine, E. R. Phillips, M. W. Lee, M. R. Ansari, G. B. Talpos, and A. M. Parfitt Effect of Vitamin D Nutrition on Parathyroid Adenoma Weight: Pathogenetic and Clinical Implications J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1054 - 1058. [Abstract] [Full Text]

				W. G Goodman, S. Misra, J. D Veldhuis, A. A Portale, H.-J. Wang, M. E Ament, and I. B Salusky Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 560 - 568. [Abstract] [Full Text] [PDF]

				S. J. Silverberg, E. Shane, T. P. Jacobs, E. Siris, and J. P. Bilezikian A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery N. Engl. J. Med., October 21, 1999; 341(17): 1249 - 1255. [Abstract] [Full Text] [PDF]

				S. J. Silverberg, J. P. Bilezikian, H. G. Bone, G. B. Talpos, M. J. Horwitz, and A. F. Stewart To Treat or Not To Treat: Conclusions from the NIH Consensus Conferencea J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2275 - 2278. [Full Text]

				H. G. Bone Who Needs Parathyroid Surgery? The Case for Parathyroidectomy in Nonclassical Primary Hyperparathyroidismb J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2278 - 2282. [Full Text]

				E. Lundgren, E. Szabo, S. Ljunghall, R. Bergström, L. Holmberg, and J. Rastad Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism BMJ, September 26, 1998; 317(7162): 848 - 851. [Abstract] [Full Text]

				S. J. Silverberg, H. G. Bone, T. B. Marriott, F. G. Locker, S. Thys-Jacobs, G. Dziem, S. Kaatz, E. L. Sanguinetti, and J. P. Bilezikian Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary Hyperparathyroidism N. Engl. J. Med., November 20, 1997; 337(21): 1506 - 1511. [Abstract] [Full Text] [PDF]